Healthsense, a US-based provider of remote monitoring equipment for old people, has extended its series D round by $7m from local drugs company Merck’s corporate venturing unit and not-for-profit health care services organization Fallon Community Health Plan.
Brian Bischoff, chief executive of Healthsense, said: “The addition of respected investors and industry leaders like Merck GHIF [Global Health Innovation Fund] and Fallon Community Health Plan supports our belief that our technology and approach can both improve quality and reduce cost. Both companies represent strong strategic alliances for us at this important point in our growth.”
“The Healthsense technology and related business platform support an industry trend toward better outcomes and reduced health care costs at the most appropriate location to receive care,” added Patrick Hughes, Fallon Community Health Plan executive president.
Ziegler acted as financial adviser to Healthsense on the D round and is an investor in the company.
Its other investors include the $100m West Health Investment Fund and venture capital firm Radius Ventures.